Next generation far ultraviolet-c irradiation technology: mitigating surgical site and wound infection risk

Ended Purchase Order Awarded Last action

Contract number
FA864924P0393
Awardee
Awarding agency
Obligated
$1,249,822

Award facts

Contract value 100% obligated
$1,249,822.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 603 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Penn Valley, PA 19072, USA
Research
SBIR Program Phase II Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 · Sbir phase II proposal F2D-9256 - next-GEN far UV-c irradiation technology: mitigating surgical site and wound infection risk $0
Original award $1,249,822

About this award

The Air Force Research Laboratory awarded a $1.25 million Small Business Innovation Research (SBIR) Phase II contract to Xcmr Inc., a small business entity based in Penn Valley, Pennsylvania, on January 18, 2024. Under the firm fixed-price purchase order, Xcmr will develop next-generation far ultraviolet-C irradiation technology designed to mitigate surgical site and wound infection risks. This contract is set aside exclusively for small businesses and carries an ultimate completion date of October 17, 2025. The award reflects the Air Force's investment in innovative infection prevention solutions that could have significant applications across both military medical operations and civilian healthcare settings.

Xcmr Inc. specializes in research and development of advanced ultraviolet-C technologies and biological threat mitigation solutions. The company has established a track record with federal agencies, securing multiple SBIR and Small Business Technology Transfer contracts from both the Air Force Research Laboratory and the Environmental Protection Agency. This Phase II award builds upon Xcmr's demonstrated expertise in developing real-time pathogen inactivation systems and represents the company's most substantial federal contract to date, positioning it as a key contributor to the Department of Defense's efforts to advance infection control technologies for medical applications.

Quick answers

Who was awarded contract FA864924P0393?

FA864924P0393 was awarded to Xcmr Inc. by Air Force Research Laboratory (Air Force Materiel Command) on January 18, 2024.

How much is contract FA864924P0393 worth?

The government has obligated $1,249,822 on FA864924P0393.

Was contract FA864924P0393 competed?

The extent of competition for FA864924P0393 was full and open competition after exclusion of sources. The government received 603 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award